Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer
Clinical trial NCT00425386 · COMPLETED
Trial details
- NCT number
- NCT00425386
- Sponsor
- OHSU Knight Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2010-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.